The ruthenium-based drug NAMI-A, characterized by its selectivity against solid tumour metastases, promotes TGF-β1-dependent fibrosis and the reduction of the release of MMPs in the primary tumour. The aim of the study was to examine the interaction of NAMI-A with TGF-β1 in the process of metastasis formation. NAMI-A i) affects the secretion of TGF-β1 in metastatic MDA-MB-231 cells rather than in non-tumorigenic HBL-100 cells, ii) prevails over TGF-β1 with regard to the invasive capacity of the treated cells, and iii) contrasts integrin-dependent migration stimulated by TGF-β1. It thus appears that the effects of NAMI-A on cell invasion and migration are best summarized as an interference with TGF-β1 and a reduction of its activity in these events. At a molecular level, the similar activity of NAMI-A and TGF-β1 on RhoA GTPase supports its interaction with cell surface integrins while TGF-β1 can activate it by interaction with its TGFβR receptor. The inhibition of TGF-β1-induced migration of MDA-MB-231 cells by NAMI-A cannot simply be attributed to a modulation of the Smad2 and p38MAPK pathways. In conclusion, the effects of NAMI-A on the biological role of TGF-β1 in cancer metastasis are insufficient to attribute the responsibility for the anti-metastatic activity of the ruthenium-based drug to this target alone.

Effects of the ruthenium-based drug NAMI-A on the roles played by TGF-β1 in the metastatic process

BRESCACIN, LAURA;MASI, ALESSIA;SAVA, GIANNI;BERGAMO, ALBERTA
2015

Abstract

The ruthenium-based drug NAMI-A, characterized by its selectivity against solid tumour metastases, promotes TGF-β1-dependent fibrosis and the reduction of the release of MMPs in the primary tumour. The aim of the study was to examine the interaction of NAMI-A with TGF-β1 in the process of metastasis formation. NAMI-A i) affects the secretion of TGF-β1 in metastatic MDA-MB-231 cells rather than in non-tumorigenic HBL-100 cells, ii) prevails over TGF-β1 with regard to the invasive capacity of the treated cells, and iii) contrasts integrin-dependent migration stimulated by TGF-β1. It thus appears that the effects of NAMI-A on cell invasion and migration are best summarized as an interference with TGF-β1 and a reduction of its activity in these events. At a molecular level, the similar activity of NAMI-A and TGF-β1 on RhoA GTPase supports its interaction with cell surface integrins while TGF-β1 can activate it by interaction with its TGFβR receptor. The inhibition of TGF-β1-induced migration of MDA-MB-231 cells by NAMI-A cannot simply be attributed to a modulation of the Smad2 and p38MAPK pathways. In conclusion, the effects of NAMI-A on the biological role of TGF-β1 in cancer metastasis are insufficient to attribute the responsibility for the anti-metastatic activity of the ruthenium-based drug to this target alone.
File in questo prodotto:
File Dimensione Formato  
Effects of the ruthenium-based drug NAMI-A.pdf

non disponibili

Descrizione: PDF versione editoriale
Tipologia: Documento in Versione Editoriale
Licenza: Digital Rights Management non definito
Dimensione 1.08 MB
Formato Adobe PDF
1.08 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
775_2015_1297_MOESM1_ESM.pdf

non disponibili

Descrizione: Materiale supplementare
Tipologia: Altro materiale allegato
Licenza: Digital Rights Management non definito
Dimensione 147.03 kB
Formato Adobe PDF
147.03 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
775_2015_1297_MOESM2_ESM.pdf

non disponibili

Descrizione: Materiale supplementare
Tipologia: Altro materiale allegato
Licenza: Digital Rights Management non definito
Dimensione 90.5 kB
Formato Adobe PDF
90.5 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11368/2871883
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 19
social impact